Skip to main content

Conference Correspondent

News, views, and coverage of important topics and discussions from oncology conferences and events.

[widgetkit id="1" name="CC Event Nav"]

Unsupervised Hierarchical Clustering of Surface Antigen Expression to Identify Patients with Normal Karyotype AML with Distinct Disease Characteristics and Poor Outcome

Improved Survival with Fludarabine and Timed Sequential Busulfan Regimen in Older Patients with AML or MDS

Allogeneic Transplant Leads to Markedly Improved Survival in Older Patients with Acute Myeloid Leukemia

Nivolumab with Azacytidine in Patients with Relapsed AML

Suboptimal Adherence to Guideline-Recommended Molecular Testing in Patients with Newly Diagnosed AML: Data from the Connect MDS/AML Disease Registry

Effect of Cytarabine/Anthracycline/Crenolanib Induction on MRD in Newly Diagnosed FLT3 Mutant AML

Findings from the Connect MM Registry: Changes in Treatment Patterns in Patients with Newly Diagnosed Multiple Myeloma

Carfilzomib, Pomalidomide, and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma

Elotuzumab, Lenalidomide, and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma

Response-Adapted Therapy for Newly Diagnosed Myeloma

14
15
16
17
18
19
20

Page 17 of 25
Results 161 - 170 of 242